The new FDA guidelines for AI in healthcare, effective January 2026, aim to establish a robust regulatory framework for AI-driven medical devices, ensuring safety, efficacy, and trustworthiness for patients and providers in the United States.
U.S. healthcare providers must understand and implement five critical compliance steps to navigate the new FDA AI healthcare regulations set to go live in January 2026, ensuring patient safety and operational integrity.